Naltrexone Poa Pharma (Naltrexone Hydrochloride)

Naltrexone works by competitively binding to mu, kappa, and delta opioid receptors in the central nervous system. By occupying these receptors without activating them, it prevents endogenous and exogenous opioids from producing their typical euphoric and reinforcing effects, thereby diminishing cravings and the risk of relapse.

The specific dosage and regimen of Naltrexone Poa Pharma are determined by the prescribing healthcare professional based on the individual’s clinical condition, treatment goals, and response. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for naltrexone in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefits justify any potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any required import documentation.

Naltrexone differs from opioid agonist therapies such as methadone or buprenorphine because it blocks opioid receptors rather than activating them. This antagonistic action eliminates opioid‑induced euphoria but requires patients to be opioid‑free before initiation. It is often chosen for individuals seeking a non‑opioid maintenance option or for relapse prevention after detoxification.

Naltrexone Poa Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

The medication is supplied as an oral tablet and is taken by mouth with water. It is usually administered once daily, but the exact timing and any food considerations are determined by the prescribing clinician based on the patient’s overall treatment plan.

Serious risks include hepatotoxicity, which may manifest as elevated liver enzymes or liver injury, and severe depression or suicidal ideation, especially in patients with a history of mood disorders. Prompt medical evaluation is essential if any signs of liver dysfunction or worsening mental health occur.

Naltrexone is contraindicated in individuals currently using opioid analgesics or undergoing opioid maintenance therapy, as it can precipitate acute withdrawal. It should also be avoided in patients with severe hepatic impairment or known hypersensitivity to naltrexone or any of the tablet’s excipients.